Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$726M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$599M |
| 3 |
Apple
AAPL
|
+$578M |
| 4 |
Meta Platforms (Facebook)
META
|
+$328M |
| 5 |
American Airlines Group
AAL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Gilead Sciences
GILD
|
+$392M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$285M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$225M |
| 5 |
Intel
INTC
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.51% |
| 2 | Technology | 3.09% |
| 3 | Consumer Discretionary | 2.15% |
| 4 | Financials | 1.67% |
| 5 | Healthcare | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCIJ
4176
DELISTED
Global X Scientific Beta Japan ETF
SCIJ
| $2.52M | ﹤0.01% |
+100,000
| New | +$2.52M |
|
|
NVO
4177
CALL
Novo Nordisk
NVO
$202B
| $2.52M | ﹤0.01% |
92,000
-14,200
| -13% | -$399K |
|
4178
CALL
Ultragenyx Pharmaceutical
RARE
$2.52B
| $2.52M | ﹤0.01% |
24,600
+10,700
| +77% | +$831K |
|
4179
ProShares Ultra 20+ Year Treasury
UBT
$58M
| $2.52M | ﹤0.01% |
72,294
-21,418
| -23% | -$821K |
|
4180
CALL
Shutterstock
SSTK
$221M
| $2.52M | ﹤0.01% |
42,900
+18,900
| +79% | +$1.24M |
|
4181
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $2.52M | ﹤0.01% |
47,614
+33,896
| +247% | +$1.8M |
|
4182
MSCI
MSCI
$41.5B
| $2.51M | ﹤0.01% |
40,833
-8,552
| -17% | -$530K |
|
4183
PUT
ProShares Ultra Materials
UYM
$41.7M
| $2.51M | ﹤0.01% |
211,200
+123,200
| +140% | +$1.59M |
|
4184
KLA
KLAC
$229B
| $2.51M | ﹤0.01% |
446,520
-345,110
| -44% | -$2.02M |
|
|
RSPP
4185
PUT
DELISTED
RSP Permian, Inc.
RSPP
| $2.51M | ﹤0.01% |
89,300
-54,400
| -38% | -$1.55M |
|
|
SSRI
4186
CALL
DELISTED
Silver Standard Resources
SSRI
| $2.51M | ﹤0.01% |
399,300
+24,800
| +7% | +$146K |
|
|
SGMO
4187
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.51M | ﹤0.01% |
226,000
-110,400
| -33% | -$1.42M |
|
4188
Ally Financial
ALLY
$12.8B
| $2.5M | ﹤0.01% |
111,672
-56,182
| -33% | -$1.24M |
|
4189
Tractor Supply
TSCO
$18.1B
| $2.5M | ﹤0.01% |
139,270
+5,485
| +4% | +$97.3K |
|
|
DOC
4190
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.5M | ﹤0.01% |
162,956
+36,456
| +29% | +$604K |
|
|
PRXL
4191
PUT
DELISTED
Parexel International Corp
PRXL
| $2.5M | ﹤0.01% |
38,900
+24,300
| +166% | +$1.64M |
|
4192
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$258M
| $2.5M | ﹤0.01% |
32,395
+9,957
| +44% | +$777K |
|
4193
PUT
iShares US Financial Services ETF
IYG
$2.23B
| $2.5M | ﹤0.01% |
79,800
+36,000
| +82% | +$1.12M |
|
4194
CALL
Carter's
CRI
$1.23B
| $2.5M | ﹤0.01% |
23,500
-9,300
| -28% | -$933K |
|
4195
Quaker Houghton
KWR
$2.85B
| $2.5M | ﹤0.01% |
28,105
+15,205
| +118% | +$1.31M |
|
4196
PUT
iShares MSCI Italy ETF
EWI
$1.12B
| $2.5M | ﹤0.01% |
83,100
+36,050
| +77% | +$1.11M |
|
4197
PUT
Keysight
KEYS
$54.5B
| $2.5M | ﹤0.01% |
80,000
+49,100
| +159% | +$1.68M |
|
4198
WisdomTree
WT
$3.7B
| $2.49M | ﹤0.01% |
113,508
-231,673
| -67% | -$4.89M |
|
4199
Invesco DB Base Metals Fund
DBB
$368M
| $2.49M | ﹤0.01% |
173,169
+36,583
| +27% | +$564K |
|
|
SYNH
4200
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.49M | ﹤0.01% |
62,100
+29,300
| +89% | +$1.01M |
|
Similar funds
Jeff Yass's Q2 2015 Portfolio in Review
As of Q2 2015, Jeff Yass held 10,941 positions worth $235B, up 6.8% from $220B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q2 2015 filing shows 1,599 new, 4,693 increased, 3,596 reduced and 888 closed positions. Its largest new stake was Vanguard Global ex-US Real Estate ETF: 1,789,597 shares worth $99.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 87% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2015 buy was Vanguard Global ex-US Real Estate ETF: 1,789,597 shares worth $99.3M.
- Jeff Yass added most to Alphabet (Google) Class C in Q2 2015, an estimated $726M increase.
- Jeff Yass's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.17B.
- Jeff Yass fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $41.7M.
- Jeff Yass's ten largest holdings make up 24% of its $235B portfolio in Q2 2015.
- Jeff Yass opened 1,599 new positions and closed 888 in Q2 2015.
- Jeff Yass's portfolio value rose 6.8% quarter-over-quarter to $235B.
Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.